These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2693444)

  • 21. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of ofloxacin (OFLX) on urinary tract infections].
    Miyata M; Inagaki N; Inada F; Yachiku S; Okamura K; Osanai H; Mizunaga M; Morikawa M
    Hinyokika Kiyo; 1987 Aug; 33(8):1303-11. PubMed ID: 3480688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefotaxime and cefazolin in the treatment of complicated urinary tract infections: a comparative study.
    Madsen PO; Iversen P
    Clin Ther; 1981; 4(1):7-11. PubMed ID: 6268298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the clinical effects of cefotiam on acute cystitis and changes in form of E. coli in the urine].
    Washida H; Tsugaya M; Hirao N; Hachisuka Y; Takeuchi K; Inuzuka K
    Hinyokika Kiyo; 1983 Oct; 29(10):1373-80. PubMed ID: 6100419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli.
    Balagué C; Stürtz N; Rey R; De Ruiz CS; Nader-Macías ME; Duffard R; De Duffard AM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):337-46. PubMed ID: 17034416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity and clinical evaluation of cefixime in urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 1998 Apr; 81(4):301-4. PubMed ID: 9623027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
    Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
    J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections.
    Velasco M; Horcajada JP; Mensa J; Moreno-Martinez A; Vila J; Martinez JA; Ruiz J; Barranco M; Roig G; Soriano E
    Clin Infect Dis; 2001 Nov; 33(10):1682-6. PubMed ID: 11595990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pyuria, bacteriuria and urinary tract infections in hospitalized patients with spinal cord injuries].
    Tysnes OB; Krokeide M; Bjerke L; Digranes A
    Tidsskr Nor Laegeforen; 1996 Aug; 116(18):2172-4. PubMed ID: 8801659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
    Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
    Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between hemolysin production and acute inflammation in human urinary tract infection.
    Connell H; de Man P; Jodal U; Lincoln K; Svanborg C
    Microb Pathog; 1993 Jun; 14(6):463-72. PubMed ID: 7692210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of cefotiam (CGP/14221) versus cephalothin in the treatment of urinary tract infections.
    Tselentis J; Cordossis T; Eliopoulos G
    Pharmatherapeutica; 1983; 3(6):382-7. PubMed ID: 6312460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.